Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 607 of the 607 references it cites were found in a registry or an index.

Sickle-cell disease

Abstract

Sickle-cell disease is one of the most common severe monogenic disorders in the world. Haemoglobin polymerisation, leading to erythrocyte rigidity and vaso-occlusion, is central to the pathophysiology of this disease, although the importance of chronic anaemia, haemolysis, and vasculopathy has been established. Clinical management is basic and few treatments have a robust evidence base. One of the main problems of sickle-cell disease in children is the development of cerebrovascular disease and cognitive impairment, and the role of blood transfusion and hydroxycarbamide for prevention of these complications is starting to be understood. Recurrent episodes of vaso-occlusion and inflammation result in progressive damage to most organs, including the brain, kidneys, lungs, bones, and cardiovascular system, which becomes apparent with increasing age. Most people with sickle-cell disease live in Africa, where little is known about this disease; however, we do know that the disorder follows a more severe clinical course in Africa than for the rest of the world and that infectious diseases have a role in causing this increased severity of sickle-cell disease. More work is needed to develop effective treatments that specifically target pathophysiological changes and clinical complications of sickle-cell disease.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(10)61029-x

Cites

607 of 607 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 607 references

Cited by

See all 2,504

Metadata

Authors
Rees, D. C., Williams, T. N., & Gladwin, M. T.
Affiliations
  • King's College London (GB)
  • Kenya Medical Research Institute (KE)
  • University of Pittsburgh (US)
Venue
The Lancet
Publisher
Elsevier BV
Published
2010-12
Volume
376
Issue
9757
Pages
2018-2031
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2053495832
Cited by
2,504
References
607
Citations by year
2026: 160 · 2025: 175 · 2024: 197 · 2023: 267 · 2022: 232 · 2021: 221 · 2020: 206 · 2019: 195 · 2018: 171 · 2017: 144 · 2016: 148 · 2015: 111 · 2014: 96 · 2013: 83 · 2012: 64
FWCI
6.07
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • Wellcome Trust (091758, 076934/Z/05/Z)
  • Hemophilia Center of Western Pennsylvania
  • National Heart, Lung, and Blood Institute (R01HL098032)
  • National Institute of Diabetes and Digestive and Kidney Diseases (RC1DK085852)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR058910)
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
Keywords
sickle cell disease, vascular occlusion, hemolytic anemia, organ damage, hydroxyurea, stem cell transplantation, gene therapy, genome editing, stroke risk screening, iron overload, magnetic resonance imaging, point-of-care testing, hemolysis, pregnancy management, cerebrovascular disease prevention
MeSH terms
Africa, Anemia, Sickle Cell, Antisickling Agents, Blood Transfusion, Disease Susceptibility, Erythrocytes, Haplotypes, Heart Diseases, Hematopoietic Stem Cells, Hemolysis, Humans, Hydroxyurea, Hypertension, Pulmonary, Iron Chelating Agents, Kidney Diseases, Mass Screening, Nervous System Diseases, Pain, Severity of Illness Index, Gene Transfer Techniques, Hematopoietic Stem Cell Transplantation, Acute Chest Syndrome, Polymerization, Pain Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sickle-cell disease. https://app.cochat.ai/papers/10.1016/s0140-6736(10)61029-x
The paper
Rees, D. C., Williams, T. N., & Gladwin, M. T. (2010). Sickle-cell disease. The Lancet. https://doi.org/10.1016/s0140-6736(10)61029-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.